Royal London Asset Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $102M | Sell |
280,510
-852
| -0.3% | -$292K | 0.19% | 108 |
|
|
2026
Q1 | $99M | Buy |
281,362
+2,083
| +0.7% | +$743K | 0.21% | 102 |
|
|
2025
Q4 | $91.4M | Sell |
279,279
-2,497
| -0.9% | -$792K | 0.19% | 107 |
|
|
2025
Q3 | $79.5M | Sell |
281,776
-6,604
| -2% | -$1.92M | 0.17% | 119 |
|
|
2025
Q2 | $80.5M | Sell |
288,380
-8,069
| -3% | -$2.29M | 0.18% | 108 |
|
|
2025
Q1 | $92.4M | Buy |
296,449
+65,659
| +28% | +$19.4M | 0.22% | 88 |
|
|
2024
Q4 | $60.2M | Buy |
230,790
+1,424
| +0.6% | +$422K | 0.15% | 124 |
|
|
2024
Q3 | $73.9M | Buy |
229,366
+6,447
| +3% | +$2.11M | 0.18% | 105 |
|
|
2024
Q2 | $69.7M | Buy |
222,919
+5,389
| +2% | +$1.58M | 0.18% | 96 |
|
|
2024
Q1 | $61.8M | Sell |
217,530
-1,087
| -0.5% | -$318K | 0.15% | 120 |
|
|
2023
Q4 | $63M | Sell |
218,617
-486
| -0.2% | -$132K | 0.18% | 108 |
|
|
2023
Q3 | $58.9M | Buy |
219,103
+16,910
| +8% | +$4.22M | 0.19% | 105 |
|
|
2023
Q2 | $44.9M | Buy |
202,193
+10,930
| +6% | +$2.54M | 0.15% | 128 |
|
|
2023
Q1 | $46.2M | Buy |
191,263
+4,114
| +2% | +$1.01M | 0.19% | 110 |
|
|
2022
Q4 | $49.2M | Buy |
187,149
+5,919
| +3% | +$1.59M | 0.22% | 92 |
|
|
2022
Q3 | $40.9M | Sell |
181,230
-19,934
| -10% | -$4.83M | 0.21% | 94 |
|
|
2022
Q2 | $49M | Hold |
201,164
| – | – | 0.23% | 90 |
|
|
2022
Q1 | $48.6M | Buy |
201,164
+6,098
| +3% | +$1.4M | 0.19% | 104 |
|
|
2021
Q4 | $43.9M | Sell |
195,066
-9,694
| -5% | -$2.05M | 0.16% | 116 |
|
|
2021
Q3 | $43.5M | Sell |
204,760
-6,202
| -3% | -$1.43M | 0.18% | 114 |
|
|
2021
Q2 | $51.4M | Sell |
210,962
-4,419
| -2% | -$1.09M | 0.21% | 103 |
|
|
2021
Q1 | $53.6M | Buy |
215,381
+589
| +0.3% | +$141K | 0.25% | 92 |
|
|
2020
Q4 | $49.4M | Sell |
214,792
-12,709
| -6% | -$2.93M | 0.26% | 82 |
|
|
2020
Q3 | $56.5M | Sell |
227,501
-2,656
| -1% | -$658K | 0.34% | 66 |
|
|
2020
Q2 | $53.3M | Sell |
230,157
-8,074
| -3% | -$1.84M | 0.37% | 61 |
|
|
2020
Q1 | $49.7M | Sell |
238,231
-1,603
| -0.7% | -$350K | 0.4% | 60 |
|
|
2019
Q4 | $57.6M | Buy |
239,834
+1,029
| +0.4% | +$227K | 0.4% | 56 |
|
|
2019
Q3 | $46.2M | Buy |
+238,805
| New | +$45.8M | 0.35% | 67 |
|
|
2019
Q2 | – | Sell |
-250,821
| Closed | -$47.6M | – | 561 |
|
|
2019
Q1 | $47.6M | Sell |
250,821
-21,931
| -8% | -$4.19M | 0.37% | 61 |
|
|
2018
Q4 | $52M | Buy |
272,752
+13,494
| +5% | +$2.63M | 0.46% | 50 |
|
|
2018
Q3 | $53.7M | Sell |
259,258
-36,116
| -12% | -$7.12M | 0.55% | 38 |
|
|
2018
Q2 | $54.5M | Buy |
+295,374
| New | +$52.2M | 0.55% | 34 |
|
|
2016
Q2 | $38.9M | Sell |
255,575
-27,455,363
| -99% | -$4.27B | 0.63% | 34 |
|
|
2016
Q1 | $185K | Buy |
27,710,938
+27,439,466
| +10,108% | +$4.08B | 0.26% | 90 |
|
|
2015
Q4 | $44.3M | Buy |
271,472
+2,586
| +1% | +$406K | 0.68% | 32 |
|
|
2015
Q3 | $37.2M | Buy |
+268,886
| New | +$42.4M | 0.6% | 36 |
|
|
2014
Q3 | – | Sell |
-175,893
| Closed | -$22.4M | – | 536 |
|
|
2014
Q2 | $22.4M | Sell |
175,893
-790
| -0.4% | -$91.5K | 0.51% | 39 |
|
|
2014
Q1 | $19.7M | Sell |
176,683
-5,203
| -3% | -$631K | 0.46% | 50 |
|
|
2013
Q4 | $21.5M | Buy |
181,886
+3,722
| +2% | +$423K | 0.54% | 40 |
|
|
2013
Q3 | $20.7M | Buy |
178,164
+2,097
| +1% | +$227K | 0.55% | 40 |
|
|
2013
Q2 | $17.4M | Buy |
+176,067
| New | +$18.3M | 0.51% | 39 |
|
Other funds holding AMGN
Royal London Asset Management's AMGN Position: Q2 2026 in Review
Royal London Asset Management reduced its Amgen (AMGN) stake by 0.3% in Q2 2026, selling an estimated $292K and leaving 280,510 shares worth $102M. The position accounts for 0.19% of the portfolio, ranked #108.
Royal London Asset Management first reported a position in AMGN in Q2 2013 and has held it in 41 quarters since. 3,137 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Royal London Asset Management held 280,510 shares of Amgen worth $102M as of Q2 2026.
- Royal London Asset Management sold 852 Amgen shares in Q2 2026, an estimated $292K.
- Amgen made up 0.19% of Royal London Asset Management's portfolio in Q2 2026, its #108 holding.
- Royal London Asset Management first reported a position in Amgen in Q2 2013 and has held it in 41 quarters since.
- 3,137 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Royal London Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.